Imatinib

• Target:

  C-Kit|||SARS-CoV|||PDGFR|||Autophagy|||Bcr-Abl

• Related Pathways:

  Cytoskeletal Signaling|||Tyrosine Kinase/Adaptors|||Microbiology/Virology|||Autophagy|||Angiogenesis

• Purity:

  >99.99%

• Bioactivity:

  Imatinib (STI571) is a multi-targeted receptor tyrosine kinase inhibitor that selectively inhibits the kinase activities of BCR/ABL, v-Abl, PDGFR, and c-kit with oral activity. Imatinib has antitumor activity for the treatment of chronic granulocytic leukemia.

• Smiles:

  CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC(=CC=N3)C3=CC=CN=C3)=C(C)C=C2)CC1

• Molecular Formula:

  C29H31N7O

• Molecular Weight:

  493.6

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  152459-95-5